HIV Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV stocks.

HIV Stocks Recent News

Date Stock Title
Aug 1 GSK US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
Aug 1 GSK GSK wins FDA nod to expand Jemperli label in uterine cancer
Aug 1 LH Labcorp Holdings Inc (LH) Q2 2024 Earnings Call Transcript
Aug 1 LH Labcorp (LH) Q2 Earnings Surpass Estimates (revised)
Aug 1 GSK Who's to blame as Moderna's stock falls amid slashed guidance?
Aug 1 LH LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Aug 1 GILD Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Aug 1 LH Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase
Aug 1 LH Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics
Aug 1 LH Labcorp (LH) Beats Q2 Earnings and Revenue Estimates
Aug 1 LH Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall
Aug 1 LH Labcorp beats Q2 profit and revenue estimates on demand for health tests
Aug 1 LH Labcorp: Q2 Earnings Snapshot
Aug 1 LH Laboratory Corporation of America beats top-line and bottom-line estimates; updates FY24 outlook
Aug 1 LH Labcorp Announces 2024 Second Quarter Results
Jul 31 GSK GSK Q2 Earnings Review: Vaccine Issues Aside, A Strong Quarter
Jul 31 GSK GSK: Good Earnings Report, But Risks Ahead (Rating Downgrade)
Jul 31 GSK GSK plc (GSK) Q2 2024 Earnings Call Transcript
Jul 31 LH Laboratory Corporation of America Q2 2024 Earnings Preview
Jul 31 LH What's in Store for These 4 MedTech Stocks in Q2 Earnings?
HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

Browse All Tags